Trends in the use of antihypertensive drugs in France from 2002 to 2012: FLAHS surveys;Évolution dans l'usage des traitements antihypertenseurs en France entre 2002et 2012: Enquêtes FLAHS

Annales de Cardiologie et d'Angeiologie

Volumn 62, Issue 3, 2013, Pages 210-214

  Girerd, X ^a,b   Hanon, O ^a,c   Pannier, B ^a,d   Vaisse B ^a,e   Mourad, J J ^a,f  

^a Comité français de lutte contre l'hypertension artérielle ^*  (France)

^b U Prev Maladies Cardiovasculaires   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔpital F H Manhès   (France)

^e HÔpital de la Timone   (France)

^f HÔpital Avicenne   (France)

Author keywords

Antihypertensive drugs; Arterial hypertension; Fixed dose combination; FLAHS survey

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; DRUG USE; FRANCE; HEALTH SURVEY; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MONOTHERAPY; PILL; PRESCRIPTION; TREND STUDY;

ANTIHYPERTENSIVE DRUGS; ARTERIAL HYPERTENSION; COMBINAISON FIXE D'ANTIHYPERTENSEUR; ENQUÊTE FLAHS; FIXED-DOSE COMBINATION; FLAHS SURVEY; HYPERTENSION ARTÉRIELLE; TRAITEMENTS ANTIHYPERTENSEURS;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUESTIONNAIRES; SAMPLING STUDIES; TREATMENT OUTCOME;

EID: 84880034946     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2013.04.011     Document Type: Article

References (6)

1. Samson S, Ricordeau P, Pepin S, Tilly B, Weill A, Allemand H.Hypertension artérielle et facteurs de risque associés: évolutions des traitements entre 2000et 2006. Points de Repère de la CNAMTS No10, http://www.ameli.fr/.
2. Girerd X., Herpin D., Postel-Vinay N., Vaïsse B., Poncelet P., Mallion J.M., et al. Évolution dans l'utilisation des traitements non médicamenteux et médicamenteux pour le traitement de l'hypertension artérielle en France. Enquête FLAHS 2004. Arch Mal Coeur 2005, 98:813-816.
3. Girerd X., Laroche P., Hanon O., Pannier B., Postel-Vinay N., Mourad J.J. Use of antihypertensive drugs in France and relationship with cardiovascular disease. FLAHS 2009-2010surveys. Ann Cardiol Angeiol (Paris) 2012, 61(3):213-217.
4. Weber M.A., Jamerson K., Bakris G.L., Weir M.R., Zappe D., Zhang Y., et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet 2013, 381:537-545.
5. Blacher J., Halimi J.M., Hanon O., Mourad J.J., Pathak A., Schnebert B., et al. Prise en charge de l'hypertension artérielle de l'adulte. Recommandations 2013de la Société française d'hypertension artérielle. Presse Med 2013, 41(3):221-224.
6. Mourad J.J., Girerd X. Objective for 2015: 70% of treated and controlled hypertensive patients. Seven key points to reach this goal in practice. A joint call for action of the French League Against Hypertension and the French Society of Hypertension. J Mal Vasc 2012, 37(6):295-299.